1. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06% 
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W. Georgitis, MDb, Jay Grossman, MDc, Paul H. Ratner, MDd, David G. Tinkelman, MD, Paul Roszko, RPhe, Elena Zegarelli, PhDe, Chester C. Wood, MDe 
Journal of Allergy and Clinical Immunology 
Volume 95, Issue 5, Pages (May 1995)
DOI: /S (95)
Copyright © 1995 Mosby, Inc. Terms and Conditions

2. FIG. 1
Patient and physician assessments of the long-term efficacy of IB in treating PAR.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

3. FIG. 1
Patient and physician assessments of the long-term efficacy of IB in treating PAR.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

4. FIG. 1
Patient and physician assessments of the long-term efficacy of IB in treating PAR.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

5. FIG. 1
Patient and physician assessments of the long-term efficacy of IB in treating PAR.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions

6. FIG. 2
Quality of life assessment after 1 year of therapy with IB for PAR.
Journal of Allergy and Clinical Immunology  , DOI: ( /S (95) )
Copyright © 1995 Mosby, Inc. Terms and Conditions